The solution has still only been approved in the United States for investigational use.
“This is a procedure that’s done once, and it keeps giving a benefit over time,” one researcher said. “This is going to prevent thousands of strokes.”
Percutaneous edge-to-edge mitral valve repair was associated with improved outcomes among TAVR patients with persistent mitral regurgitation.
Low levels of residual mitral regurgitation after TEER can make a big impact on patient outcomes, researchers explained in a new analysis.
Researchers found that the procedure was associated with a high success rate and low mortality and stroke rates after 30 days.
To build and validate their advanced AI model, researchers explored data from nearly 78,000 TAVR hospitalizations.
The study’s authors developed and validated a new performance measure for TAVR care using data from more than 52,000 patients. They shared their full analysis ahead of print in Circulation.
When patients with post-TAVR infective endocarditis have a stroke, their risk of in-hospital mortality and all-cause mortality after one year both skyrocket.
Researchers emphasized the importance of these findings, noting that hypertension can lead to significant cardiovascular complications.
Researchers in Germany explored data from more than 400 TAVR patients, sharing their findings in the Journal of the American College of Cardiology.
The findings, published in the Journal of the American College of Cardiology, focused on data from the VIVID registry.
Researchers presented 30-day data at the SCAI 2021 Scientific Sessions, highlighting the "excellent" outcomes and the importance of constantly working to improve patient care.